A Novel Surrogate Nomogram Capable of Predicting OncotypeDX Recurrence Score©

Background: OncotypeDX Recurrence Score© (RS) is a commercially available 21-gene expression assay which estimates prognosis and guides chemoendocrine prescription in early-stage estrogen-receptor positive, human epidermal growth factor receptor-2-negative (ER+/HER2−) breast cancer. Limitations of R...

Descripción completa

Detalles Bibliográficos
Autores principales: Davey, Matthew G., Jalali, Amirhossein, Ryan, Éanna J., McLaughlin, Ray P., Sweeney, Karl J., Barry, Michael K., Malone, Carmel M., Keane, Maccon M., Lowery, Aoife J., Miller, Nicola, Kerin, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318604/
https://www.ncbi.nlm.nih.gov/pubmed/35887614
http://dx.doi.org/10.3390/jpm12071117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318604/
https://www.ncbi.nlm.nih.gov/pubmed/35887614
http://dx.doi.org/10.3390/jpm12071117

Ejemplares similares